Macquarie Group
ONCS

Macquarie Group’s OncoSec Medical Incorporated ONCS Stock Holding History

Macquarie Group’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-23
Closed -$8K – 2516
2017
Q4 		$8K Buy
+23
New +$8.06K ﹤0.01% 2326

Other funds holding ONCS

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Macquarie Group's ONCS Position: Q1 2018 in Review

Macquarie Group sold out of OncoSec Medical Incorporated (ONCS) in Q1 2018, closing a stake of 23 shares — an estimated $8K sold.

Macquarie Group first reported a position in ONCS in Q4 2017 and held it in 1 quarter. The position peaked at $8K in Q4 2017. 38 funds tracked by Wall St. Rank hold ONCS as of Q1 2018.

  • Macquarie Group reported no remaining OncoSec Medical Incorporated position as of Q1 2018 after selling out during the quarter.
  • Macquarie Group sold 23 OncoSec Medical Incorporated shares in Q1 2018, an estimated $8K.
  • Macquarie Group first reported a position in OncoSec Medical Incorporated in Q4 2017 and held it in 1 quarter.
  • Macquarie Group's OncoSec Medical Incorporated position peaked at $8K in Q4 2017.
  • 38 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2018.

Based on Macquarie Group's 13F filing for Q1 2018, filed 11 May 2018.